Listeria costaricensis is the official name given to the new bacterial species described by investigators from the Costa Rican Institute of Technology (TEC) and the WHO-collaborating center on Listeria at Institut Pasteur.
Listeria is a bacterial genus comprising 18 species. Two of them are pathogenic to humans and animals, upon consumption of contaminated food. Listeria monocytogenes, the best characterized pathogenic species, can cause gastroenteritis, septicemia and central nervous system infection, mostly in immunocompromised individuals, as well as fetal and neonatal infection.
While the new species Listeria costaricensis is non-pathogenic, its characterization will nonetheless increase our understanding of the pathogenic potential of Listeria. “The discovery of Listeria costaricensis will allow comparisons with pathogenic Listeria species, in order to better understand the behavior and adaptations of these bacterial pathogens,” explained TEC biotechnologist Kattia Núñez.
Listeria costaricensis was isolated from water collected at an industrial drainage area in the Costa Rican province of Alajuela, after three years of sample collection and research. “In Costa Rica, there have been few studies on microbiological diversity. Our recent finding reflects the biodiversity of Costa Rican soils and suggests that this Central American country is a fertile environment for this type of research,” added Javier Pizarro-Cerda, Research Director at the Institut Pasteur, who participated in the study and now heads the Yersinia Research Unit. For Marc Lecuit, head of Biology of Infection Unit at Institut Pasteur and French National Reference Center for Listeria (page in French), this collaboration illustrates the public health and scientific dimensions of the activities of the WHO-collaborating center on Listeria, which assists colleagues from around the world on the characterization of Listeria isolates.